Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Shunsuke Teraoka (Kobe city, Japan), Shunsuke Teraoka, Daichi Fujimoto, Munehiro Ito, Yoshihiro Nakagawa, Jiro Ito, Mariko Kogo, Yuki Sato, Kato Ryoji, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Yukimasa Hatachi, Keisuke Tomii. Intolarence of pirfenidone and its associated factors in the real world. Eur Respir J 2016; 48: Suppl. 60, 786

Member's Comments

No comment yet.

Related content which might interest you: The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Interstitial lung diseases today Source: Eur Respir Mon; 2009: 46: 1–3 Year: 2009 Interstitial lung disease associated with polymyositis-dermatomyositis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 Interstitial lung diseases, mortality and associated risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Nintedanib reduces fibrotic markers in the lung in a model of rheumatoid arthritis associated interstitial lung disease Source: International Congress 2016 – ILD pathogenesis Year: 2016 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Interstitial lung disease Source: School Course 2012 - Thoracic Imaging Year: 2012 Interstitial lung disease Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases Year: 2019 Interstitial lung disease Source: Eur Respir Monogr 2014; 66: 218-231 Year: 2014 Interstitial lung disease Source: ERS Course 2018 - Thoracic imaging Year: 2018 Interstitial lung disease Source: International Congress 2015 – Interstitial lung disease, pulmonary hypertension, pulmonary embolism and sleep apnoea Year: 2015 Interstitial lung disease Source: Eur Respir Monogr 2019; 83: 173-187 Year: 2019 Interstitial lung disease Source: Eur Respir Rev 2014; 23: 40-54 Year: 2014 Interstitial lung disease Source: ERS Course 2015 Year: 2015